论文信息 - RUXOLITINIB COMPARED WITH BEST AVAILABLE THERAPY FOR ESSENTIAL THROMBOCYTHAEMIA PATIENTS RESISTANT OR INTOLERANT TO HYDROXYCARBAMIDE IN MAJIC - AN INVESTIGATOR LEAD RANDOMIZED TRIAL - 字舞流文

RUXOLITINIB COMPARED WITH BEST AVAILABLE THERAPY FOR ESSENTIAL THROMBOCYTHAEMIA PATIENTS RESISTANT OR INTOLERANT TO HYDROXYCARBAMIDE IN MAJIC - AN INVESTIGATOR LEAD RANDOMIZED TRIAL

A. Mead | C. Yap | A. Dueck | R. Mesa | M. McMullin | N. Panoskaltsis | C. Harrison | H. Geyer | J. Coppell | M. Wood | Sonia Fox | A. Panchal | A. Houlton | R. Scherber | Frederick Chen | S. Aliman